It is noteworthy that the high level of SCD-1 expression and subsequently higher levels of monounsaturated fatty acids have also been related to higher cancer death in patients affected by obesity [24], conferring more benefits to the use of nisin as a health-protective agent. Here, SCD is linked to obesity due to melanocortin 4 receptor deficiency.